0001179110-19-007875.txt : 20190619
0001179110-19-007875.hdr.sgml : 20190619
20190619160207
ACCESSION NUMBER: 0001179110-19-007875
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190617
FILED AS OF DATE: 20190619
DATE AS OF CHANGE: 20190619
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Turitz Andrew
CENTRAL INDEX KEY: 0001726221
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37477
FILM NUMBER: 19906085
MAIL ADDRESS:
STREET 1: C/O TELADOC, INC.
STREET 2: 2 MANHATTANVILLE ROAD, SUITE 203
CITY: PURCHASE
STATE: NY
ZIP: 10577
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Teladoc Health, Inc.
CENTRAL INDEX KEY: 0001477449
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011]
IRS NUMBER: 043705970
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2 MANHATTANVILLE ROAD
STREET 2: SUITE 203
CITY: PURCHASE
STATE: NY
ZIP: 10577
BUSINESS PHONE: 2036352002
MAIL ADDRESS:
STREET 1: 2 MANHATTANVILLE ROAD
STREET 2: SUITE 203
CITY: PURCHASE
STATE: NY
ZIP: 10577
FORMER COMPANY:
FORMER CONFORMED NAME: Teladoc, Inc.
DATE OF NAME CHANGE: 20091123
4
1
edgar.xml
FORM 4 -
X0306
4
2019-06-17
0
0001477449
Teladoc Health, Inc.
TDOC
0001726221
Turitz Andrew
C/O TELADOC HEALTH, INC.
2 MANHATTANVILLE ROAD, SUITE 203
PURCHASE
NY
10577
0
1
0
0
SVP - Business Development
Common Stock
2019-06-17
4
M
0
2840
12.21
A
6826
D
Common Stock
2019-06-17
4
M
0
4167
22.30
A
10993
D
Common Stock
2019-06-17
4
M
0
2150
38.55
A
13143
D
Common Stock
2019-06-17
4
S
0
9157
60.05
D
3986
D
Employee Stock Option (right to buy)
12.21
2019-06-17
4
M
0
2840
0.00
D
2026-03-07
Common Stock
2840
8522
D
Employee Stock Option (right to buy)
22.30
2019-06-17
4
M
0
4167
0.00
D
2027-03-03
Common Stock
4167
29171
D
Employee Stock Option (right to buy)
38.55
2019-06-17
4
M
0
2150
0.00
D
2028-03-01
Common Stock
2150
23650
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 4, 2019.
Represents the weighted average price of transactions ranging from $60.00 to $60.18. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
The option vests as to 25% of the shares on March 7, 2017. The remainder of the shares vest in 36 equal monthly installments thereafter.
The option vests as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter.
The option vests as to 25% of the shares on March 1, 2019. The remainder of the shares vest in 36 equal monthly installments thereafter.
/s/ Adam C. Vandervoort, attorney-in-fact
2019-06-19